
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy
Tao Xie, Xian‐Lu Song, Chong Wang, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 5, pp. 1293-1301
Open Access | Times Cited: 11
Tao Xie, Xian‐Lu Song, Chong Wang, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 5, pp. 1293-1301
Open Access | Times Cited: 11
Showing 11 citing articles:
RNA methylation and cancer treatment
Baochen Yang, Jing‐Quan Wang, Yao Tan, et al.
Pharmacological Research (2021) Vol. 174, pp. 105937-105937
Open Access | Times Cited: 163
Baochen Yang, Jing‐Quan Wang, Yao Tan, et al.
Pharmacological Research (2021) Vol. 174, pp. 105937-105937
Open Access | Times Cited: 163
Sympathetic signaling facilitates progression of neuroendocrine prostate cancer
Shubham Dwivedi, Maricris Bautista, Sanskriti Shrestha, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 24
Shubham Dwivedi, Maricris Bautista, Sanskriti Shrestha, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 24
The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer
Eleazer P. Resurreccion, Ka-wing Fong
Metabolites (2022) Vol. 12, Iss. 6, pp. 488-488
Open Access | Times Cited: 17
Eleazer P. Resurreccion, Ka-wing Fong
Metabolites (2022) Vol. 12, Iss. 6, pp. 488-488
Open Access | Times Cited: 17
Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment
Tomoyuki Makino, Kouji Izumi, Atsushi Mizokami
Biomedicines (2021) Vol. 9, Iss. 4, pp. 414-414
Open Access | Times Cited: 21
Tomoyuki Makino, Kouji Izumi, Atsushi Mizokami
Biomedicines (2021) Vol. 9, Iss. 4, pp. 414-414
Open Access | Times Cited: 21
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
Shuhei Kamada, Shinichi Sakamoto, Ryo Kinoshita, et al.
The Prostate (2024) Vol. 84, Iss. 7, pp. 636-643
Closed Access | Times Cited: 2
Shuhei Kamada, Shinichi Sakamoto, Ryo Kinoshita, et al.
The Prostate (2024) Vol. 84, Iss. 7, pp. 636-643
Closed Access | Times Cited: 2
Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta‐analysis
Daniele Tienforti, Chiara Castellini, Francesca Di Giulio, et al.
Andrology (2023) Vol. 11, Iss. 6, pp. 1067-1076
Closed Access | Times Cited: 7
Daniele Tienforti, Chiara Castellini, Francesca Di Giulio, et al.
Andrology (2023) Vol. 11, Iss. 6, pp. 1067-1076
Closed Access | Times Cited: 7
Bipolar Androgen Therapy: When Excess Fuel Extinguishes the Fire
Nima Nabavi, Seied Rabi Mahdavi, Mohammad Afshar Ardalan, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2084-2084
Open Access | Times Cited: 5
Nima Nabavi, Seied Rabi Mahdavi, Mohammad Afshar Ardalan, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2084-2084
Open Access | Times Cited: 5
Clinical response in metastatic castration‐resistant prostate cancer (mCRPC) cases treated with supra‐physiological doses of testosterone: Bipolar androgen therapy
Senji Hoshi, Vladimir Bilim, Kiyotsugu Hoshi, et al.
Clinical Case Reports (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 4
Senji Hoshi, Vladimir Bilim, Kiyotsugu Hoshi, et al.
Clinical Case Reports (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 4
Testosterone therapy in prostate cancer: is it still a controversy?
Alex S. Bart, Alexander Van Hoof, Ryan Badre-Hume, et al.
Current Opinion in Urology (2022) Vol. 32, Iss. 6, pp. 598-606
Closed Access | Times Cited: 1
Alex S. Bart, Alexander Van Hoof, Ryan Badre-Hume, et al.
Current Opinion in Urology (2022) Vol. 32, Iss. 6, pp. 598-606
Closed Access | Times Cited: 1
Emphasizing the Role of Multi-omics Approach to Increase Survival Rate of Breast and Prostate Cancer Patients
Khushali Upadhyay, Foram Patel, Y. Patel, et al.
Journal of Endocrinology & Reproduction (2023), pp. 147-155
Open Access
Khushali Upadhyay, Foram Patel, Y. Patel, et al.
Journal of Endocrinology & Reproduction (2023), pp. 147-155
Open Access
Pros and cons of hormone replacement therapy
A.A. Zinoviev, A. V. Lokhmacheva
Scientific Bulletin of the Omsk State Medical University (2023) Vol. 3, Iss. 1, pp. 59-70
Open Access
A.A. Zinoviev, A. V. Lokhmacheva
Scientific Bulletin of the Omsk State Medical University (2023) Vol. 3, Iss. 1, pp. 59-70
Open Access